Home Newsfeeds ENDRA Life Sciences Q3 EPS $(0.05), Inline

ENDRA Life Sciences Q3 EPS $(0.05), Inline

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Morgan Stanley Maintains Equal-Weight on Hubbell, Raises Price Target to $238

By Benzinga Newsdesk

February 1, 11:11 AM

Morgan Stanley analyst Joshua Pokrzywinski maintains Hubbell (NYSE:HUBB) with a Equal-Weight and raises the price target from $226 to $238.

HUBB

JMP Securities Reiterates Market Outperform on Viant Technology, Maintains $6 Price Target

By Benzinga Newsdesk

Yesterday, 8:52 AM

JMP Securities analyst Andrew Boone reiterates Viant Technology (NASDAQ:DSP) with a Market Outperform and maintains $6 price target.

DSP

Telefonica To Cut Around 5,100 Jobs In Spain By 2026: Report

By Lekha Gupta

December 5, 6:37 AM

Spain's leading telecom company, Telefonica SA (NYSE: TEF), reportedly disclosed to the unions its plans to cut about 5,100 jobs in Spain by 2026. The move reflects efforts to lower costs and adapt the company's size to the current market, reported Reuters.

TEF